Evidence map›Paper›PMID 39246432›Full record

ArticleBreeding science2024

Genome editing of

Ai Nagamine, Hiroshi Ezura

Abstract read
In one paragraph

Article in Breeding science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. CRISPR/Cas9-mediated knockout ofFrontiers in genome editing · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ai NagamineInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennnodai, Tsukuba, Ibaraki 305-8572, Japan.
Hiroshi EzuraInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennnodai, Tsukuba, Ibaraki 305-8572, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant factories with artificial light are less affected than open-air areas to environmental factors in crop cultivation and are attracting attention as one of the solutions to the world's food problems. However, the cost of cultivation in plant factories is higher than open-air cultivation, and currently, profitable factory-grown crop varieties are limited to those that are small or have a short growing period. Tomatoes are one of the main crops consumed around the world, but due to their large plant height and width, they are not yet suitable for mass production in plant factories. In this study, the

Indexed as

CRISPR–Cas9DWARF (D)GABAgenome editingplant factorySELF-PRUNING (SP)tomato

Identifiers

PMID39246432
PMCPMC11375428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.